The move would follow a similar agreement with Pfizer. Other companies are engaged in talks with the White House that would help them avoid tariffs on their products overseas.
Category: Soriot, Pascal
-
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.